February 2 RxAdvocate September, 2022 — Newsletter
September Stories:
- Malaria Vaccine
- Botox Rival Revance Gets U.S. Approval
- COVID-19 Vaccine Boosters
- Organizational Announcement
- Team Community Involvement
New “World-Changing” Malaria Vaccine
Scientists at the University of Oxford have developed a vaccine with the potential to end one of the largest plagues humanity has faced – Malaria. Trial results from over 400 children show up to 80% protection against a disease that kills over 400,000 people per year.
Scientists say their vaccine is inexpensive and the world’s largest vaccine manufacturer (Serum Institute of India) is poised to make more than 100 million doses annually.
There are 229 million cases of Malaria each year with 94% of them originating in Africa. The disease is caused by a parasite spread by mosquitoes.
Botox Rival Revance Gets U.S. Approval
The aesthetic market dominated by Botox might have a new contender. Revance Therapeutics and their brand Daxxify have shown almost 6 months of lasting effects of anti-wrinkle injection.
With this timeline, as compared to 3-4 months from Botox, Revance could assert themselves as serious competitors in the $3.2 billion dollar market for injectable facial treatments.
COVID-19 Vaccine Boosters
COVID-19 Vaccine Boosters
The virus that causes Covid-19 continuously changes with time and immunity from previous vaccines decreases over time, therefore keeping your protection current is important.
The updated Covid-19 vaccine boosters were developed to expand protection against Covid-19, including stronger protection against variants such as Omicron. These new boosters are called bivalent Covid-19 vaccines. These vaccines help protect from severe illness, hospitalization and death from Covid-19.
Organizational Announcement
Organizational Announcement
Josh Hall is an Account Manager for RxConnection. As an Account Manager, Josh provides internal support to the Strategic Account Executives to deliver optimal client service.
Josh graduated from Youngstown State University with a Bachelor in Exercise Science as well as course work in Health & Human Services. Josh has experience working in the healthcare industry as well as administrative roles in collegiate athletics.
Team Community Involvement
Team Community Involvement
RxConnection’s Managing Principal, Orlando Neal, and his foundation are pleased to have participated in the WISN 12 NEWS Class Act School Supply Drive in partnership with the The Salvation Army Milwaukee County, assisting youth with getting started on the right foot!
The Curtis D. Neal foundation is dedicated to youth development and encouragement. Their collaborative programs and resources build confidence, promote healthy lifestyle choices, and foster positive relationships. Click here for more.
RxConnection’s Strategic Account Executive, Christina Hollis, participated in The Children’s Heart Foundation’s annual Congenital Heart Fundraiser to raise awareness and support heart warriors and their families.
Christina’s daughter, Greta, was diagnosed with Hypoplastic Left Heart Syndrome (HLHS) and is part of the 1 in every 110 babies diagnosed with Congenital Heart Disease (CHD).
Click here to learn more about CHD and how you can help.
RxConnection’s Senior Analyst, Shane Tedford, hosts a 5k in his father’s memory every November, with proceeds going to sports scholarships.
To join the 5k and find out more about the memorial, click here
Contact us
Visit us on the web at www.rxconnectionllc.com.
If you would like additional information on our services please contact:
Orlando Neal — Principal
Orlando.Neal@rxconnectionllc.com
Orlando.Neal@rxconnectionllc.com